Page last updated: 2024-11-02

oxybutynin and Dyspnea

oxybutynin has been researched along with Dyspnea in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Dyspnea: Difficult or labored breathing.

Research Excerpts

ExcerptRelevanceReference
"Delirium is a common distressing symptom observed in patients with terminal respiratory diseases and is treated with antipsychotic medications such as haloperidol."8.31Efficacy of blonanserin transdermal patch on terminal delirium in patients with respiratory diseases. ( Ando, K; Suzuki, A; Yoshida, H, 2023)
"Delirium is a common distressing symptom observed in patients with terminal respiratory diseases and is treated with antipsychotic medications such as haloperidol."4.31Efficacy of blonanserin transdermal patch on terminal delirium in patients with respiratory diseases. ( Ando, K; Suzuki, A; Yoshida, H, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ando, K1
Suzuki, A1
Yoshida, H1

Other Studies

1 other study available for oxybutynin and Dyspnea

ArticleYear
Efficacy of blonanserin transdermal patch on terminal delirium in patients with respiratory diseases.
    Respiratory investigation, 2023, Volume: 61, Issue:2

    Topics: Antipsychotic Agents; Delirium; Dyspnea; Haloperidol; Humans; Retrospective Studies; Transdermal Pat

2023